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Abstract
Background: Considering the significant prevalence of Neonatal Indirect Hyperbilirubinemia (NIH) and its
irreversible neurological complications, identifying the factors involved in the prevalence of neonatal jaundice is
essential. The present study was conducted to determine the relationship between serum vitamin D levels and the
prevalence of NIH in infants admitted to Qods Hospital of Qazvin in Iran in 2015–16.
Methods: In this case-control study, 30 term infants with NIH (the case group) were compared with 30 healthy,
non- icteric, term infants (the control group) in terms of serum levels of 25-hydroxyvitamin D. The results were
analyzed and compared between the two groups using t-test and the Chi-square test.
Results: The mean and standard deviation of serum 25-hydroxyvitamin D levels were 10.76 ± 8.6 ng/dl in the case group
and 14.88 ± 11.38 ng/dl in the control group. There were no significant differences between the two groups (P = 0.11).
Conclusion: The results suggest the lack of a relationship between vitamin D levels and NIH. However, further
prospective studies are needed to conclude that vitamin D has no role in the pathogenesis of NIH.
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Background
Neonatal indirect hyperbilirubinemia (NIH) is a prevalent
issue among newborns [1]. NIH may has some detrimen-
tal complications such as long term neurologic deficits
and death [2]. Any problem which rises bilirubin produc-
tion and decreases conjugation can cause NIH [3]. Some
of the causes of neonatal jaundice include blood group in-
compatibility, sequestration, G6PD deficiency, polycy-
themia and infections, while in most cases, there are no
known causes [4]. Recent studies have shown the presence
of vitamin D receptors in some of the cells derived from
different tissues such as the liver, pancreas, brain and
prostate as well as on the surface of immune cells, includ-
ing lymphocytes and macrophages [5, 6]. Moreover, vita-
min D activation occurs through 25-hydroxylation in the
liver followed by 1-hydroxylation in the kidney [7, 8]. This
metabolite can also be synthesized in various cells, includ-
ing monocytes, skin cells and the placenta during preg-
nancy [9]. The liver tissue is not only involved in vitamin
D synthesis, but also plays a key role in converting indirect
bilirubin to direct bilirubin [10]. The metabolisms of bili-
rubin and vitamin D happen in two separate paths, but
they may affect each other since one stage of their synthe-
sis takes place in liver. The 25-hydroxylation stage, one of
the main phases of vitamin D synthesis, takes place in the
liver, as well as bilirubin conjugation [11]. So far, few stud-
ies have examined the relationship between hyperbilirubi-
nemia and neonatal serum vitamin D [12, 13]. Given the
high prevalence of jaundice and the importance of identi-
fying its risk factors, understanding the relationship be-
tween these two can play a positive role in the diagnosis
and treatment of neonatal jaundice. The present study
was therefore conducted to investigate the relationship be-
tween serum vitamin D levels and hyperbilirubinemia in
infants admitted to Qods Hospital in 2015–16.
Methods
In this case-control study, 30 eligible infants with hyper-
bilirubinemia were compared with 30 healthy infants ad-
mitted to Qods Hospital in Qazvin, Iran, after obtaining
a written consent from their parents. Hyperbilirubinemia
was determined by bilirubin test that determine the bili-
rubin level in blood. Increasing of the bilirubin level
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more than 5 mg/dl was considered as hyperbilirubine-
mia. The infants were examined in terms of serum 25-
hydroxyvitamin D level over 1 year. The term infants
with a gestational age of 37–42 weeks and a postnatal
age of three to 10 days, weighing 2500–4000 g and with
no evidence of apparent anomalies, congenital anomal-
ies, hematoma or symptoms suggesting infections as
confirmed by a physician entered the study. Moreover,
the infants with Rh or ABO incompatibility and with
urinary infection, hypothyroidism, and children with dir-
ect or conjugated bilirubin> 0.8 were excluded from the
study. The two groups were homogenized in terms of
confounding and underlying variables such as age, gen-
der, birth weight, gestational age, type of delivery, type of
nutrition, place of residence, vitamin D supplementation
during pregnancy, the mothers’ disease history, the
mothers’ medication history, the families’ socioeconomic
status, the mothers’ and the infants’ 25-hydroxyvitamin
D level and the infants’ Ca (calcium), P (phosphorus),
ALP (Alkaline phosphatas) and Mg (magnesium) levels.
Infants whose mothers had a history of liver, kidney, thy-
roid and metabolic diseases such as diabetes or con-
sumed a specific medication such as anticonvulsants
were excluded from the study. The hospitalized icteric
infants who were candidates for phototherapy based on
the American Academy of Pediatrics entered the study
after undergoing the required tests and the rejection of
hemolytic icterus, sequestration, polycythemia and infec-
tions by a neonatologist. The infants’ weight, height and
head circumference were measured by standard methods
(the infants were weighed with a Seca weighing scale
with a precision of 500 g). To measure serum 25-
hydroxyvitamin D levels, 3 cm3 of blood was taken from
the infants, its serum was separated, and stored in a
freezer at − 20 °C until the test time. Considering the
potential impact of phototherapy on serum vitamin D
levels, the first serum sample of the icteric infants before
the phototherapy was used for the tests. The 25-
hydroxyvitamin D test was performed with the ELISA
method (EIA or enzyme immunoassay), an ELISA
Reader device called Awareness (made in the US), kits
with a 2.7 ng/ml sensitivity and a batch number =
34,408, 33,737 (made by IDS in Germany) at the labora-
tory of Qods Hospital. All the biochemical and bilirubin
tests were performed using photometry with an Auto
Analyzer (Prestige 24i model, made in Japan), and the
Ca level was measured with the help of Cresolphthalein
Complexone, P with a UV test, ALP using the DGKC’s
(German Society for Clinical Chemistry’s) method, Mg
with Xylidyl Blue and total bilirubin with 2,4-dichloroa-
niline DCA. Based on the available sources of data,
serum 25-hydroxyvitamin D levels were categorized as
follows [14]: Very severe vitamin D deficiency = Less
than 5 ng/ml, Severe vitamin D deficiency = 5–10 ng/ml,
Vitamin D deficiency = 10–20 ng/ml, Suboptimal vita-
min D provision = 20–30 ng/ml, Optimal vitamin D
level = 30–50 ng/ml Upper normal = 50–70 ng/ml.
Data were statistically analyzed in SPSS-16. The fre-
quency percentage, mean and standard deviation were
used for the descriptive analysis of the data. The t-test
was used to compare the two groups in terms of the
mean quantitative variables and the Chi-squared test to
compare them in terms of the mean qualitative variables.
Data was statistically significant at P < 0.05.
Results
In this study, 60 term infants admitted to Qods Hospital
of Qazvin were examined in two groups, including 30
infants with hyperbilirubinemia who were candidates for
phototherapy in the case group and 30 healthy infants
without jaundice in the control group. None of the sub-
jects withdrew from the study, and the number of pa-
tients in each of the case and control groups remained
the same until the very end. All the infants were breast-
fed and none had started receiving supplementation with
formula. The mothers’ type of clothing was similar in
the two groups. All the infants were cared for by their
mothers and they were all Iranian in ethnicity. The in-
fants were compared between the two groups in terms
of demographic variables, including gender, age, birth
weight, weight at the time of the visit (postnatal weight),
height, head circumference, gestational age and type of
delivery. No significant differences were observed be-
tween the two groups (Table 1); (P > 0.05). There were
no significant differences between the two groups in
terms of maternal variables such as the mothers’ age,
BMI, vitamin D supplementation during pregnancy,
number of deliveries and number of abortions (Table 2);
(P > 0.05). There were no statistically significant differ-
ences between the two groups in terms of socioeco-
nomic status, including the number of children,
household size, the bedroom/household size ratio, family
income, place of residence (urban/rural), the mother’s
occupation and education and the father’s occupation
and education (P > 0.05). The icteric infants had a mean
hemoglobin of 16.63 ± 1.61, a mean hematocrit of 48.05
± 4.8, a mean total bilirubin of 17.55 ± 2, and a mean
indirect bilirubin of 17.12 ± 1.92. In the case group, 22
infants (73.3%) were hospitalized at Qods Hospital for
phototherapy for 2 days, six infants (20%) for 3 days,
one infant (3.3%) for 4 days and one infant (3.3%) for 5
days. The signs of jaundice appeared in the infants in
the case group three to 7 days after birth and the time
of blood sampling for measuring the vitamin D level
was three to ten days after birth in both groups and
the two groups were thus similar in terms of the time
of taking the blood samples. There were no significant
relationships between the two groups in terms of laboratory
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parameters such as Ca, P, Mg and ALP (Table 3); (P > 0.05).
The mean serum vitamin D level in the mothers was
14.72 ± 9.60 in the case group and 17.71 ± 12.66 in the
control group, suggesting the lack of a statistically signifi-
cant relationship (Fig. 1); (P = 0.119). Finally, the two
groups were compared in terms of serum vitamin D level
in the infants (i.e. the main objective of the study). The
mean serum vitamin D level was 10.76 ± 8.60 in the
icteric infants (the cases) and 14.88 ± 11.38 in the healthy
infants. Although the mean serum vitamin D level was
lower in the infants with indirect hyperbilirubinemia than
in the healthy infants, no significant differences were
observed between the two groups and serum vitamin D
level was not significantly related to neonatal jaundice
(Figs. 2 and 3); (P = 0.119).
Discussion
The study found no relationships between serum vita-
min D levels in infants and the prevalence of Neonatal
Indirect Hyperbilirubinemia (NIH). Although the mean
serum vitamin D level was lower in the infants with
NIH compared to the healthy infants, no significant
differences were observed between the two groups and
serum vitamin D level was not significantly related to
the prevalence of NIH [15]. About two-thirds of new-
borns develop clinical neonatal jaundice (serum bilirubin
level > 5 mg/dl) and more than 97% of term and preterm
infants develop biochemical hyperbilirubinemia (serum
bilirubin level > 1 mg/dl); [16, 17]. Clinical guidelines rec-
ommend identifying the causes of hyperbilirubinemia and
adopting effective prevention strategies [18]. Identifying
the treatable etiology of hyperbilirubinemia and prevent-
ing its prevalence, which comprised the objectives of the
present study, are essential. A similar prospective study by
M. Mutlu et al. [19] investigated the relationship between
vitamin D level and neonatal hyperbilirubinemia in term
infants and compared vitamin D levels in infants with
pathologic hyperbilirubinemia and healthy infants with
normal or physiological levels of bilirubin. The results
showed statistically significant differences between the
control and case groups in terms of 25-hydroxyvitamin D
levels (P = 0.01). A significant negative relationship was
also observed between vitamin D levels and the parathy-
roid hormone in the infants (P = 0.03). Mutlu’s study was
Table 1 A comparison of the mean demographic variables between the infants in the case and control groups and their
relationships
Variables Study group (n = 30) Control group (n = 30) P
Male/Female (n) 17/13 15/15 0.605
Postnatal age (day) 5.6 ± 1.75 (3–10) 6.26 ± 1.87 (3–10) 0.160
Birth weight (gr) 3266 ± 365 (2700–3950) 3287 ± 326 (2850–3820) 0.815
Postnatal weight (gr) 3215 ± 378 (2500–4100) 3244 ± 330 (2800–3800) 0.753
Head circumference (cm) 34.9 ± 1.01 (33–37) 34.98 ± 1.06 (33–37) 0.757
Height (cm) 50.43 ± 1.75 (46–53) 50.00 ± 1.41 (47–52) 0.297
Gestational age (week) 38.2 ± 1.3 (37–40) 38.4 ± 0.7 (37–40) 0.910
Delivey type: SVD/ C/S (n) 19/11 16/14 0.432
Breast feeding [n (%)] 30 (100) 30 (100) 0.321
SVD: Spontaneous vaginal delivery; C/S: Cesarean section
T-test and frequency and percentage are the tests used in this table
Table 2 Comparison of the mean demographic variables between the mothers in the case and control groups and their
relationships
Demographic characteristics of the mothers’ cases and controls [mean ± SD (min-max)]
Study group (n = 30) Control group (n = 30) P
Mother age 27.13 ± 4.45 (17–33) 26.63 ± 6.85 (15–42) 0.739
Mother BMI 27.63 ± 4.41 (21.9–36.7) 25.41 ± 3.04 (21.5–33.6) 0.280
Abortion’s number 11 8 0.584
Delivery number 60 66 0.665
Mothers’ vitamin D use:
Regularly [n (%)] 4 (13) 3 (10) 0.247
Irregularly [n (%)] 3 (10) 8 (27)
None [n (%)] 23 (77) 19 (63)
T-test and frequency and percentage are the tests used in this table
BMI: Body mass index
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Table 3 A comparison of the mean laboratory parameters in the case and control groups and their relationships [mean ± SD
(min-max)]
Variables Study group (n = 30) Control group (n = 30) P
Ca (mg/dL) 9.21 ± 0.73 (7.7–10.7) 9.30 ± 0.58 (8.2–10.4) 0.256
P (mg/dL) 5.98 ± 0.82 (4.6–7.6) 5.73 ± 0.69 (4.3–7.3) 0.173
ALP (U/L) 409 ± 102 (247–647) 373 ± 106 (232–680) 0.895
Mg (mg/dL) 1.95 ± 0.20 (1.7–2.4) 1.99 ± 0.16 (1.7–2.3) 0.075
Neonate’s 25-OH vit D (ng/mL) 10.76 ± 8.60 (0.8–30.8) 14.88 ± 11.38 (5.1–68) 0.119
< 5 ng/mL [n (%)] 5 (17) 0 (0)
5–10 ng/mL [n (%)] 16 (53) 10 (33)
10–20 ng/mL [n (%)] 3 (10) 14 (47)
20–30 ng/mL [n (%)] 5 (17) 5 (17)
30–50 ng/mL [n (%)] 1 (3) 0 (0)
50–70 ng/mL [n (%)] 0 (0) 1 (3)
Mother’s 25-OH vit D (ng/mL) 14.72 ± 9.6 (3.6–44.9) 17.71 ± 12.66 (5.0–72.8) 0.307
< 5 ng/mL [n (%)] 2 (7) 0 (0)
5–10 ng/mL [n (%)] 12 (40) 8 (27)
10–20 ng/mL [n (%)] 7 (23) 12 (40)
20–30 ng/mL [n (%)] 7 (23) 7 (23)
30–50 ng/mL [n (%)] 2 (7) 2 (7)
50–70 ng/mL [n (%)] 0 (0) 1 (3)
Ca calcium, P phosphate, ALP alkaline phosphatase, Mg magnesium, 25-OH vit D 25-hydroxy vitamin D
t-test and frequency and percentage tests are used in this table
Fig. 1 The relationship between serum vitamin D levels in the mothers and the infants’ indirect bilirubin levels: Indicates the lack of a relationship
and correlation between the two variables (Pearson’s Correlation Coefficient = 0.97)
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conducted over 1 year on infants aged three to ten days
and born at a gestational age of 37–40 weeks who had a
serum bilirubin level requiring phototherapy (group 1 or
the case group) and healthy infants of the same age but
without jaundice or with physiological jaundice only
(group 2 or the control group). Both groups were exam-
ined at identical time periods in terms of their birth
weight, gestational age, neonatal age, weight at the visit,
type of delivery, gender, type of nutrition, mother’s age,
mother’s type of clothing, place of residence (geographical
region), vitamin D supplementation during pregnancy, the
mother’s disease history and the mother’s medication his-
tory during the pregnancy, which could affect the level of
vitamin D. Infants born to mothers with symptoms of
chronic liver disease and kidney disease or those who
regularly used anticonvulsants were excluded from the
Fig. 2 The relationship between serum vitamin D levels and indirect bilirubin in the infants: Indicates the lack of a relationship and correlation
between the two variables (Pearson’s Correlation Coefficient = 0.64)
Fig. 3 The relationship between serum vitamin D levels in the infants and the mothers: Indicates the lack of a relationship and correlation
between the two variables (Pearson’s Correlation Coefficient = 0.00)
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study [19]. Just as in the discussed study, the present study
considered all these criteria, with few differences, includ-
ing examining infants with a gestational age of 37 to
42 weeks and following up on all the infants in the control
group until 15 days and eliminating the cases of physio-
logical jaundice from the control group, such that even
suspicions about very mild jaundice only in the sclera
meant exclusion from the study. The groups were also ho-
mogenized in terms of their demographic variables and
socioeconomic status. A study by E. Dan-Ierodiaconou et
al. (1980) on the effect of phototherapy on vitamin D me-
tabolism examined ten infants with jaundice under photo-
therapy treatment. The infants’ 25-OHD, 24, 25(OH)2D,
Ca and P levels were measured before phototherapy and
24 and 48 h after the procedure was over. The mean
weight of the infants was 3.4 kg, their mean age 64 h, their
mean bilirubin level was 17.1 mg and their mean duration
of phototherapy 83 h. The causes of jaundice included
G6PD deficiency, Rh incompatibility, blood type incom-
patibility and unknown factors. For their phototherapy,
the infants were placed under seven lamps positioned
60 cm above them and were fed with cow’s milk contain-
ing no vitamin D. The results of the study showed that the
skin of infants with jaundice treated with phototherapy
does not convert pro-vitamin D to active vitamin D [20–
22]. A similar study by Gillies DR et al. (1984) on the ef-
fect of phototherapy in infants with neonatal jaundice on
the production of vitamin D measured the 25(OH) VitD
level before and 48 h after phototherapy. The results of
the study showed no significant increase in active vitamin
D levels 48 h after phototherapy [23]. Given the disparities
in the results of the discussed studies and the potential
impact of phototherapy on serum vitamin D levels, blood
samples from the case group were sent to the laboratory
for measuring the infants’ serum vitamin D level before
starting phototherapy in the present study. In Mutlu’s
study, hemogram, peripheral smear, reticulocyte count,
blood group, direct Coombs, bilirubin, free T4, TSH, Ca,
P, Mg, ALP, PTH and 25(OH) VitD testing was performed
on all the infants. Ca, P, Mg, ALP, PTH, 25(OH) VitD and
blood group testing was performed on all the mothers
too. Given the existing imitations, the present study mea-
sured only Ca, P, Mg, ALP and 25(OH) VitD in the infants
and 25(OH) VitD in the mothers. The objective of the
present study was to evaluate the relationship between
hyperbilirubinemia and serum vitamin D levels –not to
assess the etiology of vitamin D deficiency; as a result,
PTH, TSH and free T4 were not measured in this study.
Considering the exclusion of infants with physiological ic-
terus, the total and indirect bilirubin levels were not mea-
sured in the control group. Hemogram, peripheral smear,
reticulocyte count, blood group, direct Coombs and
G6PD activity testing were performed in all the icteric in-
fants in the case group and the cases of hemolytic icterus,
as diagnosed by the neonatologist, were excluded from the
study. Mutlu’s research was a case-control study with a
one-on-one design that was conducted on 51 infants,
since some of the families that were entered into the study
withdrew, and 30 infants with hyperbilirubinemia ultim-
ately remained in group 1 and 21 healthy infants remained
in group 2. In terms of laboratory parameters, bilirubin
levels were significantly higher in group 1 compared to in
group 2, while there were no statistically significant differ-
ences between the two groups in terms of Ca, P, Mg and
ALP in the infants and Ca, P, Mg, ALP, PTH and 25(OH)
VitD in the mothers. There was a significant difference be-
tween the two groups in terms of serum 25-hydroxy vita-
min D levels and a significant negative relationship was
also observed between vitamin D levels and PTH. Vitamin
D deficiency was reported in 86% of the infants in group 1
and vitamin D inadequacy was reported in 7%. The case
group had a significantly more severe degree of vitamin D
deficiency compared to the controls, but there were no
significant differences between the two groups in terms of
vitamin D inadequacy. In the present study, none of the
participants withdrew from the study because the parents
were given adequate explanations, the physician visits
were free and the families incurred no additional costs.
The findings of this study showed a statistically significant
difference between the control group and the infants with
hyperbilirubinemia in terms of 25-hydroxyvitamin D level.
There was also a significant negative relationship between
vitamin D level and the parathyroid hormone in the in-
fants. This disparity could be due to the high prevalence
of vitamin deficiency D among Iranians, which led to an
inadequate mean serum vitamin D level in both groups.
Conclusion
The result of this study showed no relationships between
vitamin D levels and NIH. In spite a fact that, a larger
statistical population was examined in this study com-
pared to previous studies, more extensive research or a
cohort study or an animal study is still needed to
generalize the result of this study.
Limitations
A multivariable linear regression model with the infants’
indirect bilirubin as the outcome measure controlling
for confounders and a regression model with infant Vita-
min D as outcome and maternal Vitamin D as exposure
to assess relationship would be helpful but unfortunately
we weren’t able to do it in this study.
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